A Study to Evaluate Safety and Tolerability of Single Ascending Doses of Rozanolixizumab Administered by Subcutaneous Infusion in Healthy Japanese, Chinese and Caucasian Study Participants
Clinical trial NCT03859219 · COMPLETED
Trial details
- NCT number
- NCT03859219
- Sponsor
- UCB Biopharma S.P.R.L.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-18
- Primary completion
- 2020-04-28
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.